Knight Therapeutics | GUD - Ebit



Knight Therapeutics reported CAD3.2M in EBIT for its fiscal quarter ending in September of 2024.


Ebit Change Date
Acasti Pharma USD -3704000 1.13M Dec/2024
Alaunos Therapeutics USD -7949000 715K Dec/2023
Aurora Cannabis CAD -17609000 54.46M Jun/2025
Avita Medical AUD -10272000 22.56M Dec/2024
Canopy Growth CAD -31497000 7.68M Jun/2025
Cronos Group USD -4384000 312K Jun/2025
Dianthus Therapeutics USD -34927000 3.01M Jun/2025
Ionis Pharmaceuticals USD 144.78M 290.78M Jun/2025
IQVIA Holdings USD 556M 187M Jun/2025
Knight Therapeutics CAD 3.2M 1.29M Sep/2024
Moderna USD -817000000 146M Jun/2025
Organigram Holdings CAD -2105000 9.2M Jun/2025
Organon & Co USD 360M 135M Jun/2025
Revvity USD 90.76M 79.15M Jun/2025
Tectonic Therapeutic USD -22332000 8.34M Jun/2025
Tilray USD -42218000 5.65M Nov/2024
Viatris USD 185.4M 628M Jun/2025
Xeris Pharmaceuticals USD 5.43M 3.75M Jun/2025